Ignite Creation Date:
2025-12-24 @ 11:40 PM
Ignite Modification Date:
2026-05-29 @ 11:30 PM
Study NCT ID:
NCT03142451
Status:
COMPLETED
Last Update Posted:
2021-01-29
First Post:
2017-04-27
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study (Study 1) to Evaluate the Safety and Efficacy of FMX103 1.5% Topical Minocycline Foam in the Treatment of Facial Papulopustular Rosacea
Sponsor:
Vyne Therapeutics Inc.
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Facial Papulopustular Rosacea | View |